The leader in quality education and networking through//conferences, courses and custom training
Connect with IBC Life Sciences:LinkedIn iconTwitter iconFacebook iconRSS icon
EmailPrint

Oligonucleotide Therapeutics Discovery

CSS

Improving Drug-Like Properties to Accelerate Preclinical and Clinical Development

Part of the TIDES Summit

May 20-23, 2012 · Mandalay Bay Resort & Casino · Las Vegas, NV

Event Overview

Event Overview

Get Up To Date Event Information

Join our priority contact list and receive the latest event news.

Special Discounted Hotel Rate

Special Discounted Hotel Rate Available Until April 3, 2012.
To book your room, call 702-632-9000 and reference IBC or TIDES.

No other event provides more new and unpublished data on all classes of oligonucleotides in preclinical and clinical development... lessons learned from multiple miRNA, siRNA, antisense, LNA, aptamer and immune modulation projects. Explore oligonucleotide delivery mechanisms and strategies for cell/tissue targeting along with novel chemical modification strategies to improve drug-like properties.

"IBC out did themselves! New, unpublished data was abundant and proof of continued innovation in bioprocessing." - Susan Dexter, BioPharm Services US

Discovery, Preclinical and Early Development Strategies for New Molecules

  • Oligonucleotide delivery mechanisms and targeting
  • Chemical modifications to improve drug-like properties
  • New data from multiple preclinical and clinical studies
  • miRNA inhibitors and non-coding RNA's
  • Antisense, siRNA, LNA, aptamers, immune modulation
  • Strategies to improve tissue and cellular uptake

Here's what other attendees said about TIDES

"Excellent oligonucleotide chemistry, discovery and optimization" - Steve Shrewsbury, AVI Biopharma

"The new format of a separate stream on Oligonucleotide Therapeutics Discovery has enhanced the value of this conference event further" - Michael Gait, Medical Research Council, United Kingdom

» Read more testimonials from the TIDES summit